Preview Mode Links will not work in preview mode

Nov 6, 2026

Featuring an interview with Dr Matthew Lunning, including the following topics:

  • Bispecific antibody/antibody-drug conjugate combinations (0:00)
  • A man in his late 90s with mantle cell lymphoma — Ann LaCasce, MD, MMSc (8:07)

CME information and select...


Nov 4, 2026

Featuring a presentation by Dr Matthew Matasar, including the following topics:

  • Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00)
  • Clinician Survey Results Regarding First-Line Treatment of DLBCL (11:41)
  • Current and Future Roles of Monoclonal and Bispecific Antibodies in...


Nov 2, 2026

Featuring an interview with Dr Matthew Lunning, including the following topics:

  • A woman in her late 70s with non-GCB diffuse large B-cell lymphoma receives pola-R-CHP — Ann LaCasce, MD, MMSc (0:00)
  • CNS prophylaxis in non-Hodgkin lymphoma (7:58)

CME information and select...


Oct 28, 2026

Featuring perspectives from Dr Lindsey Roeker, including the following topics:

  • Case: A man in his mid 60s with TP53-aberrant chronic lymphocytic leukemia (CLL) with extensive marrow infiltration receives first-line venetoclax/obinutuzumab and experiences an excellent response (0:00)
  • Case: A man in his late 70s with...


Oct 28, 2026

Featuring perspectives from Dr Lindsey Roeker, including the following topics:

  • Consensus Approach to optimizing front-line treatment (0:00)
  • Emerging role of sonrotoclax (8:39)
  • Bruton tyrosine kinase inhibitor monotherapy for older patients; discontinuation (14:48)
  • Evolving role of minimal residual disease...